These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 3094301

  • 1. [Experimental basis for the combined use of tobramycin and immune preparations for treating acute Pseudomonas aeruginosa infections].
    Minukhin VV, Tsyganenko VIa.
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):42-5. PubMed ID: 3094301
    [Abstract] [Full Text] [Related]

  • 2. [Dynamics of the contamination of mice during the treatment of burn sepsis due to Pseudomonas aeruginosa using tobramycin alone or combined with active and passive immunization].
    Minukhin VV, Tsyganenko AIa.
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Sep; (9):90-2. PubMed ID: 3098009
    [Abstract] [Full Text] [Related]

  • 3. [Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection].
    Minukhin VV, Tsyganenko AIa.
    Antibiot Khimioter; 1989 Apr; 34(4):282-6. PubMed ID: 2502083
    [Abstract] [Full Text] [Related]

  • 4. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
    Moroz AF, Kharitonova AM, Chanturiia TsK.
    Antibiotiki; 1983 May; 28(5):341-5. PubMed ID: 6410985
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of an infection due to the intraperitoneal inoculation of mice with Pseudomonas aeruginosa with tobramycin and hyperimmune Pseudomonas aeruginosa plasma used per se and in combination].
    Minukhin VV, Tsyganenko AIa.
    Antibiot Med Biotekhnol; 1986 Oct; 31(10):778-81. PubMed ID: 3098161
    [Abstract] [Full Text] [Related]

  • 6. [Effectiveness of a polyvalent corpuscular Pseudomonas aeruginosa vaccine, antibiotics and their combinations in experimental chronic Pseudomonas aeruginosa infection].
    Vetkova LG, Antsiferova NG, Radkevich SA, Moroz AF.
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Mar; (3):51-6. PubMed ID: 3922187
    [Abstract] [Full Text] [Related]

  • 7. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
    Meitert E, Sima F, Savulian C, Petrovici M, Chersulick E, Costache G.
    Arch Roum Pathol Exp Microbiol; 1989 Mar; 48(3):237-51. PubMed ID: 2519634
    [Abstract] [Full Text] [Related]

  • 8. [Immunoprophylaxis and immunotherapy of experimental Pseudomonas aeruginosa sepsis].
    Grishina IA, Terekhova RP, Marchuk AI.
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):14-7. PubMed ID: 3087118
    [Abstract] [Full Text] [Related]

  • 9. Pseudomonas aeruginosa infection: pathogenesis and therapy.
    Pennington JE.
    Compr Ther; 1979 May; 5(5):14-22. PubMed ID: 110508
    [No Abstract] [Full Text] [Related]

  • 10. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
    Ionescu A, Meitert E, Vasiliu S, Meitert T, Milicescu S, Sima F, Savulian C.
    Arch Roum Pathol Exp Microbiol; 1979 May; 38(3-4):317-30. PubMed ID: 122594
    [No Abstract] [Full Text] [Related]

  • 11. [Polish preparations for preventing and treating infections caused by Pseudomonas aeruginosa].
    Schiller B, Buchowicz I, Lysakowska E, Sakiel S, Korbecki M.
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):30-2. PubMed ID: 2409720
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns.
    Neely AN, Holder IA.
    Antibiot Chemother (1971); 1987 Apr; 39():26-40. PubMed ID: 3118788
    [No Abstract] [Full Text] [Related]

  • 15. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa. Treatment with intravenous immune globulin.
    Holder IA, Naglich JG.
    Am J Med; 1984 Mar 30; 76(3A):161-7. PubMed ID: 6424445
    [Abstract] [Full Text] [Related]

  • 16. A clinical trial of i.v. tetravalent hyperimmune Pseudomonas globulin G in burned patients.
    Hunt JL, Purdue GF.
    J Trauma; 1988 Feb 30; 28(2):146-51. PubMed ID: 3126302
    [Abstract] [Full Text] [Related]

  • 17. Efficiency of Pseudomonas aeruginosa vaccines in the prevention and treatment of Pseudomonas infections in burned patients.
    Ionescu A, Meitert E, Vasiliu S, Meitert T, Sima F, Savulian C, Milicescu S.
    Arch Roum Pathol Exp Microbiol; 1981 Feb 30; 40(4):323-32. PubMed ID: 6803737
    [No Abstract] [Full Text] [Related]

  • 18. Vaccines against Pseudomonas aeruginosa infection: 2. Clinico-immunological investigations.
    Krokhina MA, Grishina IA, Panova YuM, Terekhova RP, Severtsova MK, Yedvabnaya LS, Vaide M, Varro R, Rusanov VM, Kolker II.
    Vaccine; 1985 Sep 30; 3(3):316-24. PubMed ID: 3933202
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Our experience with the treatment of burns with sheep serum against Pseudomonas aeruginosa].
    Orłowski T, Struzyna J, Badowski A, Schiller B, Kuntze A, Kozaczek W, Goller W.
    Wiad Lek; 1980 Nov 01; 33(21):1697-701. PubMed ID: 6784349
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.